99-22604. Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 64, Number 168 (Tuesday, August 31, 1999)]
    [Notices]
    [Page 47509]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-22604]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Ophthalmic Devices Panel of the Medical Devices Advisory 
    Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Ophthalmic Devices Panel of the Medical Devices 
    Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA's regulatory issues.
        Date and Time: The meeting will be held on September 23, 1999, 8:30 
    a.m. to 5 p.m.
        Location: Holiday Inn, Lincoln Ballroom, 8777 Georgia Ave., Silver 
    Spring, MD.
        Contact Person: Sara M. Thornton, Center for Devices and 
    Radiological Health (HFZ-460), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-594-2053, or by e-mail at 
    smt@cdrh.fda.gov, or FDA Advisory Committee Information Line, 1-800-
    741-8138 (301-443-0572 in the Washington, DC area), code 12396. Please 
    call the Information Line for up-to-date information on this meeting.
        Agenda: On September 23, 1999, from 8:30 a.m. to 1:30 p.m., the 
    committee will hear formal presentations followed by public 
    participation in a discussion of keratomes. Public participants in the 
    group discussion are requested to develop a comprehensive list of 
    problems associated with keratomes, the related causes, and the steps 
    that can be taken to mitigate the problems. From 1:30 p.m. to 5 p.m., 
    the committee will discuss issues related to defining the scope and 
    purpose of a proposed keratome guidance to be developed from an outline 
    of contents currently recommended for keratome premarket notification 
    submissions. Single copies of the outline are available to the public 
    by contacting the person noted above.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by September 7, 
    1999. Formal oral presentations from the public will be scheduled 
    between approximately 9:15 a.m. and 10:15 a.m. on September 23, 1999. 
    Those desiring to make formal oral presentations should notify the 
    contact person before September 10, 1999, and submit a brief statement 
    of the general nature of the evidence or arguments they wish to 
    present, the names and addresses of proposed participants, and an 
    indication of the approximate time requested to make their 
    presentation. Those desiring to be a participant in the open group 
    discussion should notify the contact person by September 10, 1999, to 
    reserve a place at a discussion table.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: August 23, 1999.
    Linda A. Suydam,
    Senior Associate Commissioner.
    [FR Doc. 99-22604 Filed 8-30-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
08/31/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-22604
Pages:
47509-47509 (1 pages)
PDF File:
99-22604.pdf